1. Neuronal Signaling Immunology/Inflammation
  2. Amyloid-β CD47
  3. CL121

CL121 是一种 Glutaminyl Cyclase 抑制剂,对人 sQCIC50 为 0.07 μM,对人 gQCIC50 为 0.54 μM。CL121 可降低癌细胞表面焦谷氨酸 (pE) 修饰的 CD47 水平。CL121 对三阴性乳腺癌显示出抗肿瘤活性。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

CL121

CL121 Chemical Structure

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

CL121 is a Glutaminyl Cyclase inhibitor with an IC50 of 0.07 μM against human sQC and an IC50 of 0.54 μM against human gQC. CL121 reduces the level of pyroglutamate (pE)-modified CD47 on the surface of cancer cells. CL121 exhibits anti-tumor activity against triple-negative breast cancer[1].

体外研究
(In Vitro)

CL121 可强效抑制纯化的人源 sQC,其 IC50 为 0.07 μM;同时可抑制人源 gQC,其 IC50 为 0.54 μM[1]
CL121 (10-40 μM; 72 h) 可呈剂量依赖性降低 MDA-MB-231 细胞表面的 pE-CD47 修饰水平,且不影响 CD47 的总表达量[1]
CL121 (10-40 μM) 可增强巨噬细胞介导的 KYSE30 细胞吞噬作用[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay[1]

Cell Line: MDA-MB-231, KYSE30, MCF-10A, Het1A
Concentration: 50 μM
Incubation Time: 72 h
Result: Resulted in cell viability above 75% across all tested cell lines.
药代动力学
(Parmacokinetics)
Species Dose Route Cmax Tmax T1/2 CLz/F Vz/F AUC0-∞
Rat[1] 10 mg/kg i.p. 4976 ± 889 μg/L 0.25 h 2.48 ± 2.15 h 1.9 ± 0.4 L/h/kg 6 ± 3.84 L/kg 5431 ± 1253 μg/L·h
体内研究
(In Vivo)

CL121 (10-20 mg/kg;腹腔注射;每日一次;连续 3 周) 在小鼠 MDA-MB-231 异种移植模型中表现出显著的抗肿瘤活性[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: BALB/c nude (female)[1]
Dosage: 10 mg/kg; 20 mg/kg
Administration: i.p.; daily; 3 weeks
Result: Reduced average tumor volume to 154 mm3 (from 227 mm3 in controls) and average tumor weight to 129.05 mg (from 191.49 mg in controls) at 10 mg/kg, with statistically significant tumor weight reduction (P < 0.01).
Reduced average tumor volume to 195 mm3 and average tumor weight to 173.69 mg at 20 mg/kg, with no statistically significant difference compared to controls.
Significantly reduced intratumoral pE-CD47 expression relative to controls at both doses, with 10 mg/kg showing statistically significant reduction (P < 0.05) and 20 mg/kg showing stronger statistically significant reduction (P < 0.01).
Showed no significant differences in body weight between treatment groups and controls, indicating low systemic toxicity.
分子量

351.40

Formula

C20H21N3O3

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
CL121
目录号:
HY-181797
需求量: